Single Window clearance: reduced ADC referrals for non pharmaceutical and dual use items declared without API or medicinal end use. Simplification measures under SWIFT permit importers to avoid ADC referrals by declaring items listed in the PGA Exemption Category or, for dual use/excipients, by declaring non pharmaceutical grade status, absence of API, and non medicinal intended end use; sampling will be risk based with ADC officers drawing samples only as needed and repeat sampling of the same tested batch avoided. Digitally signed declarations and guarantees within the Integrated Declaration will replace hardcopy submissions, and ADC regulatory clearance will be performed at notified ports or by the nearest ADC for transshipments with IT upgrades to enable data access.
Cases where this provision is explicitly mentioned in the judgment/order text; may not be exhaustive. To view the complete list of cases mentioning this section, Click here.
Provisions expressly mentioned in the judgment/order text.
Single Window clearance: reduced ADC referrals for non pharmaceutical and dual use items declared without API or medicinal end use.
Simplification measures under SWIFT permit importers to avoid ADC referrals by declaring items listed in the PGA Exemption Category or, for dual use/excipients, by declaring non pharmaceutical grade status, absence of API, and non medicinal intended end use; sampling will be risk based with ADC officers drawing samples only as needed and repeat sampling of the same tested batch avoided. Digitally signed declarations and guarantees within the Integrated Declaration will replace hardcopy submissions, and ADC regulatory clearance will be performed at notified ports or by the nearest ADC for transshipments with IT upgrades to enable data access.
Full Summary is available for active users!
Note: It is a system-generated summary and is for quick reference only.
TaxTMI 
AI OCR ✕
of 
TaxTMI 
TaxTMI 
